trial
as of 2026-07-01A Mobile Application to Improve Case-management and Patient's Functioning in First Episode Psychosis
NCTId NCT04657380
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
168 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2022-12-04
Primary completion
2024-01-04
Eligibility
ALL · 18 Years · 30 Years
Interventions & indications
Sponsors
Hôpital le VinatierLead Sponsor
Investigators
1
Frederic HAESEBAERT, PHPrincipal Investigator
Sites
1 total
Lyon, France
Facts & assertions
4 sourced
Enrollment
168
Phase
NA
Primary Completion Date
2024-01-04
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication
investigator
person